摘要
早产儿视网膜病变(ROP)是发生于早产儿和低体重儿中的视网膜血管增生性病变,是儿童致盲的主要原因之一。研究ROP发生的危险因素、发病机制及药物干预治疗,对降低ROP的发生率和致盲率有着极其重要意义。近年来随着新生血管研究的深入,新生血管抑制剂用于预防及治疗ROP的研究也越来越多,本文拟对近年来有关ROP上述研究进展作一综述。
Retinopathy of prematurely （ROP） is a proliferative retinopathy of premature and low birth weight infants related with receiving oxygen therapy. ROP is one of the major causes of children blindness. The research on its mechanism and drug therapy of retinopathy of prematurity is important because of reduong the frequency and blindness of ROP. As the mechanism of CNV further develops in recent years, more and more researches about ROP have been undergone on neovascularization inhibitor. The main aim of this review is to introduce the new progress in the studies on ROP.
出处
《国际眼科杂志》
CAS
2006年第6期1382-1385,共4页
International Eye Science
关键词
早产儿视网膜病变
吸氧
新生血管抑制剂
retinopathy of prematurity
oxygen usage
neovascularization inhibitor
